Fabrice André

机构：Inserm, Université de Versailles Saint-Quentin-en-Yvelines, Université Paris-Saclay, Institut Gustave Roussy, Centre de recherche en Epidémiologie et Santé des Populations, Prédicteurs moléculaires et nouvelles cibles en oncologie · ORCID：0000-0001-5795-8357

发表论文 1795 篇 · 总被引 104320 次 · h-index 149

代表论文

Novae: a graph-based foundation model for spatial transcriptomics data (2025 · Nature Methods · 被引 28)
Combination of predicted sensitivity to endocrine therapy (SET2,3 index) and the recurrence score® in node-positive breast cancer: Independent validation in the PACS-01 trial (2025 · European Journal of Cancer · 被引 1)
Rb-driven transcription limits its tumour-suppressive effects in breast cancer (2026 · Nature)
Supplementary Figure S4 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors (2026)
Supplementary Table S1 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors (2026)
Supplementary Figure 6 from Recurrent Resistance Mutations to Lirafugratinib Inform Treatment Sequencing in FGFR2-Driven Tumors (2026)